Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Amarin Corp Plc (NQ: AMRN)
7.140 USD  -0.090 (-1.24%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Amarin Corp Plc
 
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Amarin Announces Notification of Patent Allowance for U.S. Application 13/614,146 Related to Vascepa(R) and FDA Approved MARINE Indication
February 07, 2013
Broadens Vascepa Claims With a Wider Range of EPA Concentrations Read More
from GlobeNewswire News Releases
Briefing: Leading Pharma Companies to Watch in Today's Market Session
February 05, 2013
from PR Newswire
Amarin Announces Notification of Additional U.S. Patent Allowance for U.S. Application 13/272,520 Based on ANCHOR Clinical Trial Results
February 01, 2013
from GlobeNewswire News Releases
Pharmaceutical Company Achieves Positive In-Vitro Testing Results Diabetes Drug
January 31, 2013
Global Pharmaceutical & Biotechnology Outlook for 2013 Continues to be Encouraging Read More
from PR Newswire
Amarin Announces Notification of Two Additional Patent Allowances for U.S. Applications (13/458,496 and 13/349,157) Related to Vascepa(R) and FDA Approved MARINE Indication
January 31, 2013
Strengthens Positioning of Vascepa for Exclusivity Into 2030 Read More
from GlobeNewswire News Releases
Amarin Announces Market Introduction of Vascepa(R) (icosapent ethyl) Capsules for the Treatment of Very High Triglycerides (VHTG)
January 24, 2013
from GlobeNewswire News Releases
Amarin Announces First Notification of U.S. Patent Allowance Based on ANCHOR Clinical Trial Results
January 23, 2013
Key 12/815,569 Patent Application Related to Patient Population With Mixed Dyslipidemia Read More
from GlobeNewswire News Releases
Amarin Announces Publication of Additional Inflammatory Marker Data From MARINE and ANCHOR Phase 3 Clinical Trials in the American Journal of Cardiovascular Drugs
January 22, 2013
Reductions in Several Inflammatory Markers Shown in Hypertriglyceridemic Patients Read More
from GlobeNewswire News Releases
Free Research Reports on AMRN, FITB, PNC and SNE Issued by the Bedford Report
January 18, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
VFC's Stock House Weekly Stock Watch, Week of 14 January
January 14, 2013
from EmailWire.Com Press Releases
Key to Success, How to Profit: MCP, FCX, AMRN and FB
January 11, 2013
from Marketwired News Releases
Amarin Announces Notification of Patent Allowance for U.S. Application 13/610,217 Related to Vascepa(R) and FDA Approved MARINE Indication
January 11, 2013
Strengthens Positioning of Vascepa for Exclusivity Into 2030 Read More
from GlobeNewswire News Releases
2013 Smartphones: EmailWire SEO Press Release Distribution Services on Smatphones Buying Guide
January 08, 2013
from EmailWire.Com Press Releases
The Real Story Behind AMRN, MDBX, ALXA and DNDN
January 07, 2013
from Marketwired News Releases
VFC's Stock House Weekly Stock Watch, Week of 7 January
January 07, 2013
from EmailWire.Com Press Releases
Australia Business News and SEO Press Release Distribution Updates on Australia-NewsWire.Com
January 05, 2013
from EmailWire.Com Press Releases
India SEO Press Release Distribution Services -- India.CityRegions Updates with Media Outlets from Indian Regions
January 04, 2013
from EmailWire.Com Press Releases
Amarin to Present at the 31st Annual J.P. Morgan Healthcare Conference
January 02, 2013
from GlobeNewswire News Releases
Amarin Announces Submission of a Supplemental New Drug Application for BASF as Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier
January 02, 2013
from GlobeNewswire News Releases
VFC's Stock House Stock Watch Wednesday, 2 January
January 02, 2013
from EmailWire.Com Press Releases
Jan 02 EmailWire SEO Press Release Distribution Service Picks: MSXX, AAPL, RIMM, YUM, AMRN, Alliance Parts and Paramount Training
January 02, 2013
from EmailWire.Com Press Releases
Strategy Behind Our Success, We Get in Early: ARNA, AAPL, AMRN and HK
December 31, 2012
from Marketwired News Releases
Strategy Behind Our Success, We Get in Early: ALXA, RAD, AMRN and HLF
December 28, 2012
from Marketwired News Releases
Special Offer for Shareholders of ALXA, RAD, AMRN and HLF
December 27, 2012
from Marketwired News Releases
Secrets to Making Money in ALXA, RAD, AMRN and HLF
December 26, 2012
from Marketwired News Releases
The Straight Truth, Investing in AAPL, MCP, AMRN and SD
December 21, 2012
from Marketwired News Releases
Strategy Behind Our Success, We Get in Early: AAPL, MCP, AMRN and SD
December 20, 2012
from Marketwired News Releases
The Reason It Trades, What's Moving SWHC, PFE, AMRN and LFVN
December 19, 2012
from Marketwired News Releases
Amarin Announces Submission of Supplemental New Drug Application for Chemport, Inc. as an Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier
December 19, 2012
from GlobeNewswire News Releases
The Real Story Behind PFE, LFVN, AMRN and HOV
December 18, 2012
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here